Mbarara Regional Referral Hospital is home to one of seven of Uganda’s public health satellite laboratories under the World Bank-funded EAPHLN Project. The hospital, commonly known as Mbarara Hospital is situated in the heart of Mbarara Municipality and is a hub for health services for the locals.
A drug and therapeutics committee (DTC) provides such a forum, allowing all the relevant people to work together to improve health care delivery, whether in hospitals or other health facilities. In many developed countries a well functioning DTC has been shown to be very effective in addressing drug use problems. However, in many developing countries DTCs do not exist and in others they do not function optimally, often due to lack of local expertise or a lack of incentives. Drug and Therapeutics Committees: A Practical Guide provides guidance to doctors, pharmacists, hospital managers and other professionals who may be serving on DTCs and/or
who are concerned with how to improve the quality and cost efficiency of therapeutic care. It is relevant for all kinds of DTCs - whether in public or private hospitals and whether at district or tertiary referral level. This comprehensive manual covers a committee’s functions and structure, the medicines
Since the publication of the first edition of Part 2 District Laboratory Practice in Tropical Countries in 2000, the work of many district laboratories continues to be dominated by the on-going HIV/AIDS pandemic, increases in the prevalence of tuberculosis and other HIV-related infections and more recently, the requirement for laboratory monitoring of antiretroviral therapy.
SMOKING already kills one in 10 adults worldwide. By 2030, perhaps a little sooner, the proportion will be one in six, or 10 million deaths per year—more than any other single cause. Whereas until recently this epidemic of chronic disease and premature death mainly affected the rich countries, it is now rapidly shifting to the developing world. By 2020, seven of every 10 people killed by smoking will be in low- and middle-income nations.
Community-based village health teams (VHTs) have long been an important component of the Uganda Ministry of Health‘s (MoH) strategies to improve access to medicines and health supplies in households facing geographic, logistic, financial, cultural, and other constraints to using and reaching formal health services. The cost-effective interventions that comprise integrated community case management (iCCM) of malaria, diarrhea, and pneumonia and family planning are the main service components of Uganda‘s community health programs.
The purpose of this report is to inform the Ministry of Health and all stakeholders of the stock levels in the country as a tool that enables appropriate logistics decisions making . This report highlights stock status, real challenges, bottlenecks but also recommends potential solutions to mitigate stock outs and expiries of ARVs & HIV test kits, ACTs, Anti-TB medicines, Reproductive Health items, selected Laboratory commodities, Vaccines and selected medicines for treatment of Opportunistic Infections In the Repubic of UgandaThis report serves to: - Act as an early warning indicator for potential stock outs and possible expiries of EMHS- Identify challenges and recommendations to avert supply interruptions- Encourage preparation and sharing of joint supply plans with stakeholders- Identify strategies for regularly reviewing supply plans for all the commodities - Encourage donors to honor their commitments in terms of quantities of products expected, timeliness of deliveries and flexibility.
Every year, an estimated 17 million people die of cardiovascular disease (CVD) (1). Three fourths of these deaths occur in low- and middle-income countries. In addition, at least one third of the world population is currently at high risk of developing major cardiovascular events; an estimated 1.3 billion due to tobacco use, 1 billion due to overweight and at least another billion due to elevated blood pressure, blood cholesterol and/or diabetes (1).
The purpose of this report is to inform the Ministry of Health and all stakeholders of the stock levels in the country as a tool that enables appropriate logistics decisions making . This report highlights stock status, real challenges, bottlenecks but also recommends potential solutions to mitigate stock outs and expiries of ARVs & HIV test kits, ACTs, Anti-TB medicines, Reproductive Health items, selected Laboratory commodities,Vaccines and selected medicines for treatment of Opportunistic Infections In the Repubic of UgandaThis report serves to: - Act as an early warning indicator for potential stock outs and possible expiries of EMHS- Identify challenges and recommendations to avert supply interruptions- Encourage preparation and sharing of joint supply plans with stakeholders- Identify strategies for regularly reviewing supply plans for all the commodities - Encourage donors to honor their commitments in terms of quantities of products expected, timeliness of deliveries and flexibility
In accordance with the Constitution of Uganda, all citizens are entitled to access high quality and cost effective public services. Efficiency, effectiveness, transparency and accountability in service delivery require that sectors and institutions develop, document, disseminate and apply standards. This will enable the sectors to be responsive to service recipients and to attain the national development objectives. A standard is defined as an established, accepted and evidence-based technical specification or basis for comparison
The World Health Organization (WHO), the United Nations Children’s Fund (UNICEF) and many other organizations are involved in the procurement of pharmaceutical products. In particular, the supply of pharmaceutical products used in the treatment of human immunodeficiency virus/acquired immunodeficiency syndrome (HIV/AIDS), malaria and tuberculosis has become a major concern at both the international and country levels. Commitments by the European Commission and G8 countries, among others, offer the potential for significant increases in funding for efforts to combat communicable diseases. Low-cost pharmaceutical products of assured quality have the greatest potential for maximizing the impact of these efforts.
In 2011, SPARS was adopted by the Ministry of Health (MoH) as a national strategy to build district level capacity in supply chain
management of medicines and health supplies. Medicines and health supplies are the second biggest expenditure in the health sector after human resources and therefore their management is critical in ensuring effective health service delivery. Experience from the last five years has shown that the Supervision, Performance, Assessment and Recognition Strategy (SPARS) can effectively improve facility performance in managing their essential medicines and health supplies through sustainably building the health worker skills, knowledge, attitudes, and practices. The purpose of these guidelines is to provide district health teams, implementing partners and donor agencies with a reference manual on what it takes to comprehensively implement SPARS. The MoH Pharmacy Department spearheaded development of these guidelines to facilitate the planning, maintenance of SPARS implementation and to ensure a quality, standardized approach in implementing this important district-level capacity building initiative.
The health sector aims to provide services of an acceptable level of quality, to ensure the clients are able to maximize the health benefits from available care. good quality of care will enhance clients satisfaction and their use of services
